Growth Metrics

BioNexus Gene Lab (BGLC) Share-based Compensation (2023 - 2025)

BioNexus Gene Lab's Share-based Compensation history spans 2 years, with the latest figure at $794770.0 for Q4 2025.

  • Quarterly results put Share-based Compensation at $794770.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $704769.0 (changed N/A YoY), and the annual figure for FY2025 was $794770.0, up 463.67%.
  • Share-based Compensation for Q4 2025 was $794770.0 at BioNexus Gene Lab, up from -$90001.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $794770.0 in Q4 2025 to a low of -$90001.0 in Q4 2023.